Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study

No abstract available.

Information

Citation

Visram A, Chan KK, Seow H, Pond G, Gayowsky A, Mohyuddin GR, McCurdy A, Sandhu I, Venner C, Lancman G, Balitsky A, Kouroukis T, Bruins R, Kumar S, Fonseca R, Mian H. Haematologica. 2024; Aug 22. [Epub ahead of print].

View Source

Contributing ICES Scientists

Research Programs

Cancer

Associated Topics

Associated Sites

ICES McMaster

Discover More

Journal Article

25/06/2026

The burden of cardiovascular disease in lymphoma survivors: a population-based matched cohort study

Yu C, Chen Y, Halajha G, Prica A, Vijenthira A, Fang J, Austin PC, Thavendiranathan P, Abdel-Qadir H. JACC Adv. 2026; 5(7): 102860. Epub 2026 Jun 25.

Journal Article

22/06/2026

The association between patient preferred language and end-of-life outcomes of home care patients who died from a cancer in Ontario, Canada – a retrospective cohort study

Wang TF, Bjerre LM, Gibb M, Yoo S, Pugliese M, Kim W, Moledina A, Engel FD, Lominy W, Carrier M, Tanuseputro P, Johnston S, Backman C. PLoS One. 2026; 21(6): e0351840.

Journal Article

22/06/2026

Application of a novel Desirability of Outcome Ranking endpoint incorporating a Framework for Resistance Assessment and Microbiologic Evaluation in antibiotic trials: a proof-of-concept in a post hoc analysis of the BALANCE trial

Ong SWX, Patrikar A, Pinto R, Mahar RK, Rishu A, Davis JS, Fowler RA, Tong SYC, Daneman N. Open Forum Infect Dis. 2026; 13(6): ofag142.

See All